Name: 1-Palmitoyl-d9-2-hydroxy-sn-glycero-3-PA
Rating: 5 (10 reviews)

有库存

sdf 文件

结构编辑

类似物检索

HIT ID:HIT214321581
Cas No:22002-85-3
常用名:1-Palmitoyl-d9-2-hydroxy-sn-glycero-3-PA
常用名:1-Palmitoyl-d9-2-hydroxy-sn-glycero-3-PA
别名:1-Hexadecanoyl-d9-2-hydroxy-sn-glycero-3-phosphate
别名:1-Hexadecanoyl-d9-2-hydroxy-sn-glycero-3-phosphate
IUPAC:[3-(hexadecanoyloxy)-2-hydroxypropoxy]phosphonic acid
IUPAC:[3-(hexadecanoyloxy)-2-hydroxypropoxy]phosphonic acid
InChI key:YNDYKPRNFWPPFU-UHFFFAOYSA-N

分子式:C19H39O7P
分子量:410.488
氢键供体数 (HBD):
氢键受体数 (HBA):
LogP:
SMILES:CCCCCCCCCCCCCCCC(=O)OCC(O)COP(O)(O)=O
SMILES:CCCCCCCCCCCCCCCC(=O)OCC(O)COP(O)(O)=O

1-Palmitoyl-d9-2-hydroxy-sn-glycero-3-PA (1-palmitoyl-d9LPA) serves as an internal standard for the quantification of 1-palmitoyl LPA using GC- or LC-MS. This compound, an analog of LPA with palmitic acid at the sn-1 position, activates reporter gene expression in PC12 cells fitted with human lysophosphatidic acid receptor 4 (LPA4) at 0.01 to 10 µM concentrations. Additionally, 1-palmitoyl LPA prompts aggregation in isolated human platelets within the 12-300 µM range, a process reversible by prostaglandin E1 (PGE1), theophylline, or EDTA. It also interacts with calcium and magnesium to boost the efficacy of ampicillin, piperacillin, and ceftazidime against P. aeruginosa strains from cystic fibrosis patients.

市场产品/服务共显示1个结果

您无法确定哪种化合物库最适合您的项目？或者您需要定制解决方案？Anymole随时为您提供帮助。

电话：400820-0310

合作：info@screeningcompound.com

技术支持：tech@screeningcompound.com

客服：service@screeningcompound.com

正在加载 ~